CrossrefInfokarte
Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics
Lung Cancer: Targets and Therapy · 2025-12 · Volume 16 · 167-198
DOI: 10.2147/lctt.s539777 ↗Abstract
Kein Abstract verfügbar.
EUVIMED